Ga-68-DOTATOC

(Ga-68-DOTATOC)

Ga-68-DOTATOC

Drug updated on 11/14/2023

Dosage FormInjection (intravenous; 18.5 MBq/mL to 148 MBq/mL (0.5 mCi/mL to 4 mCi/mL))
Drug ClassRadioactive diagnostic agents
Ongoing and Completed StudiesClinicalTrials.gov

Indication

  • Indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult and pediatric patients.